| Relationship between C－MYC Expression and the Cell Cycle in HL－6０ Cells －Flow Cytometric Analysis－ | |
Abstract/OtherAbstract
:
|
By flow cytometric measurement of cellular DNA, c-myc protein and cell volume, we attempted to assess the relationship between c-myc gene expression and the cell cycle in exponentially growing human promyrlocytic leukemia cell line (HL-60). The protein product of c-myc gene was stained by an indirect immunofluorescence method using a specific antiserum to human c-myc protein. Bivariate distributions of cellular DNA, the c-myc protein contents and cell volume demonstrated the direct evidence that the c-myc protein increases with the progression of the cell cycle and then is halved by cell division. |
Authors
:
|
Kohsuke Sasaki / Tomoyuki Murakami / Tetsuro Ogino / Manabu Takahashi |
Related Documents
:
|
0009739466 - Protein modification and degradation in the cell cycle of the yeast saccharomyces cerev... 0001681816 - Review article - defining a physiological role for the tubulin tyrosination cycle 0033382136 - Mammalian wdr12 is a novel member of the pes1–bop1 complex and is required for riboso... 0004457066 - Morphology of pbo2 in the positive plates of lead acid cells. 0007645956 - Glycosaminoglycan biosynthesis controls c. elegans vulval morphogenesis and is required... 0033058026 - A metaheuristic approach for generalized cell formation with ratio level data |
Contributors
:
|
山口大学 |
Publication Detail
:
|
Publisher : Yamaguchi University School of Medicine Type : text, Departmental Bulletin Paper Format : application/pdf |
Date Detail
:
|
2006-03-07 |
Subject
:
|
Oncogene / c-myc protein / Cell cycle / HL-60 / Flow cytometry, 医学 |
Coverage
:
|
- |
Relation
:
|
- |
Source
:
|
- |
Copyright Information
:
|
- |
Other Details
:
|
Languages : eng |
Export Citation
:
|
APA/MLA Format Download EndNote Download BibTex |
Previous Document: Induction to Granulocytic Differentiation of Human Promyelocytic Leukemia Cells （HL－6０） by P...
Next Document: Allogeneic Bone Marrow Trasplantation in Aplastic Anemia， Acute Leukemia and Malignant Lymphoma